½ÃÀ庸°í¼­
»óǰÄÚµå
1547078

¼¼°èÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)

Blood Ketone Meter Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 163 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â ¼¼°è Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ º¸°í¼­¸¦ ¹ßÇàÇß½À´Ï´Ù. º» º¸°í¼­¿¡¼­´Â ÃËÁø¿äÀΡ¤µ¿Ç⡤±âȸ¡¤°úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇÐÀ» Á¾ÇÕÀûÀ¸·Î ºÐ¼®ÇÏ¿© ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ±íÀº ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå ±Ô¸ð(2024³â) : 4¾ï 6,800¸¸ ´Þ·¯
  • ½ÃÀå ¿¹Ãø ±Ý¾×(2031³â) : 7¾ï 5,000¸¸ ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024-2031³â) : 7%

Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå - Á¶»ç ¹üÀ§:

Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀåÀº ´ç´¢º´À» °ü¸®ÇÏ´Â »ç¶÷À̳ª ÄÉÅæ ½ÄÀÌ¿ä¹ýÀ» ½ÇõÇÏ´Â »ç¶÷¿¡°Ô ÇʼöÀûÀÎ ÁöÇ¥ÀÎ Ç÷Áß ÄÉÅæ ³óµµ¸¦ ÃøÁ¤Çϱâ À§ÇØ ¼³°èµÈ ´Ù¾çÇÑ ±â±â¸¦ Æ÷°ýÇϰí ÀÖ½À´Ï´Ù. ÀÌ °èÃø±â´Â Á¤È®ÇÏ°í ½Å¼ÓÇÑ ÃøÁ¤À» Á¦°øÇϰí ÄÉÅæ ½Åü ¼öÁØÀÇ ¸ð´ÏÅ͸µ ¹× °ü¸®¿¡ Áß¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº º´¿ø, Áø·á¼Ò, ÀçÅà °³È£ µî Æø³ÐÀº ºÐ¾ß¿¡ ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ¼ºÀå ÃËÁøÀº ´ç´¢º´ÀÇ À¯º´·ü Áõ°¡, ÄÉÅæ½ÄÀÌ¿ä¹ýÀÇ Ã¤¿ë Áõ°¡, POC(Point of Care) Áø´ÜÀÇ ±â¼ú Áøº¸ÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

Ç÷Áß ÄÉÅæ ÃøÁ¤±â ¼¼°è ½ÃÀåÀ» È«º¸ÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¿©·¯ °¡ÁöÀÔ´Ï´Ù. ƯÈ÷ 1Çü ´ç´¢º´ ȯÀÚ¿¡°Ô ÄÉÅæ ¸ð´ÏÅ͸µÀº ´ç´¢º´ °ü¸®¿¡ ÇʼöÀûÀ̱⠶§¹®¿¡ ¼¼°è ´ç´¢º´ ÀÌȯÀ²ÀÇ »ó½ÂÀº Áß¿äÇÑ ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ Ã¼Áß °ü¸®¿Í Ä¡·á ¸ñÀûÀ¸·Î ÄÉÅæ½ÄÀÌ¿ä¹ýÀÇ ÀαⰡ ³ô¾ÆÁö¸é¼­ ÄÉÅæ ÃøÁ¤±â ¼ö¿ä Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. Á¤¹Ðµµ Çâ»ó, »ç¿ë ÆíÀǼº, µðÁöÅÐ Çコ Ç÷§Æû°úÀÇ ÅëÇÕ µî Ç÷Áß ÄÉÅæ ÃøÁ¤±âÀÇ ±â¼úÀû Áøº¸°¡ ½ÃÀå ¼ºÀåÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ´ç´¢º´¼º ÄÉÅ侯½Ãµµ½Ã½º(DKA)¿Í °°Àº ³ôÀº ÄÉÅæ ¼öÄ¡¿¡ µû¸¥ À§Çè¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö¸é¼­ ½Å·Ú¼º ÀÖ´Â ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:

À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí, Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀåÀº °íµµÀÇ ÄÉÅæ ÃøÁ¤±âÀÇ °í°¡ ¹× ºñ´ç´¢º´ ȯÀÚ¿¡¼­ÀÇ ±× Á߿伺ÀÇ ÀνÄÀÌ Á¦ÇÑÀûÀ̶ó´Â °ü·Ã °úÁ¦¿¡ Á÷¸é Çϰí ÀÖ½À´Ï´Ù. ¿äÁß ÄÉÅæ ½ºÆ®¸³°ú °°ÀÌ Àú·ÅÇÏÁö¸¸ Á¤È®µµ°¡ ¶³¾îÁö´Â ÄÉÅæ ½Åü ¸ð´ÏÅ͸µÀÇ ´ë¾ÈÀÌ ÀÌ¿ë °¡´ÉÇÏ´Ù´Â °ÍÀº ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀϺΠÀú°¡ Ç÷Áß ÄÉÅæ ÃøÁ¤±âÀÇ Á¤È®¼º°ú ½Å·Ú¼º¿¡ ´ëÇÑ ¿ì·Á°¡ ½ÃÀå È®´ëÀÇ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â ÀåºñÀÇ Á¤È®¼ºÀ» ³ôÀÌ°í ºñ¿ëÀ» Àý°¨Çϸç Á¤±âÀûÀÎ ÄÉÅæ ¸ð´ÏÅ͸µÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ¼ÒºñÀÚ ÀνÄÀ» ³ôÀ̱â À§ÇØ R&D¿¡ Áö¼ÓÀûÀÎ ÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù.

½ÃÀå ±âȸ:

ÀÌ ½ÃÀåÀº ÄÉÅæ ½ÄÀÌ¿ä¹ýÀÇ º¸±Þ°ú ÀçÅà ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁü¿¡ µû¶ó Å« ºñÁî´Ï½º ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ ÃßÀû ¹× ºÐ¼®À» À§ÇÑ ¸ð¹ÙÀÏ ¾Û°ú °°Àº µðÁöÅÐ Çコ ±â´ÉÀ» ÅëÇÕÇÑ Ã·´Ü Ç÷Áß ÄÉÅæ ÃøÁ¤±âÀÇ °³¹ßÀº º¸´Ù °³º°È­µÈ Æí¸®ÇÑ °Ç°­ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ÀüÀÚ»ó°Å·¡ Ç÷§Æû ¹× ¼ÒºñÀÚ Á÷Á¢ ¼­ºñ½º È®ÀåÀº ½ÃÀå ¼ºÀåÀ» À§ÇÑ »õ·Î¿î ä³ÎÀ» Á¦°øÇÏ°í ±â¾÷ÀÌ ´õ ¸¹Àº »ç¶÷µé¿¡°Ô µµ´ÞÇÏ°í ´Ù¾çÇÑ Á¦Ç°¿¡ Æí¸®ÇÑ ¾×¼¼½º¸¦ Á¦°øÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê, Áö¼Ó°¡´ÉÇÏ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ¼³°è ÅõÀÚ, Æ÷µµ´ç°ú ÄÉÅæ °ªÀ» ¸ðµÎ ÃøÁ¤ÇÒ ¼ö ÀÖ´Â ´Ù±â´É ¹ÌÅÍÀÇ Ã¤ÅÃÀº »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÏ°í ½ÃÀåÀÇ ¸®´õ½ÊÀ» À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀåÀÇ ¼¼°èÀû ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • ´Ù¾çÇÑ °Ç°­ °ü¸® ȯ°æ¿¡¼­ ¾î¶² À¯Çü°ú Çü½ÄÀÇ Ç÷Áß ÄÉÅæ ü°è°¡ äÅÃÀ» À̲ø°í Àִ°¡?
  • ±â¼úÁøº¸´Â Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå °æÀï ±¸µµ¿¡ ¾î¶² ¿µÇâÀ» ÁÖ°í Àִ°¡?
  • Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ¾îµò°¡, ¶ÇÇÑ °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
  • Ç÷Áß ÄÉÅæ ÃøÁ¤±â ¼¼°è ½ÃÀå¿¡ À־ÀÇ »õ·Î¿î µ¿Çâ°ú Àå·¡¼ºÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • ÁÖ¿ä µ¿Çâ
  • °Å½Ã°æÁ¦ ¿äÀÎ
    • ¼¼°èÀÇ ¼½Åͺ° Àü¸Á
    • ¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡ ÅëÂû

  • Á¦Ç° ä¿ë ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ¹ë·ùüÀÎ ºÐ¼®
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • »óÀ§ ½ÃÀå ºÐ¼®

Á¦4Àå °¡°Ý ºÐ¼®, 2023³â

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • Á¦Ç° °¡°Ý¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
  • °¡°Ý ºÐ¼® : Á¦Ç°º°
  • Áö¿ªº° °¡°Ý°ú Á¦Ç° ¼±È£

Á¦5Àå ¼¼°èÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • ½ÃÀå¼ö·®(´ÜÀ§) ¿¹Ãø
    • ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í Àü³â´ëºñ ¼ºÀå·ü
    • Àý´ë¾×ÀÇ ±âȸ
  • ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ºÐ¼® ¹× ¿¹Ãø
    • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®(2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø(2023-2031³â)
  • ¼¼°èÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå Àü¸Á:Á¦Ç°
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ºÐ¼®, Á¦Ç°º°(2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§)ÀÇ ºÐ¼®°ú ¿¹Ãø, Á¦Ç°º°(2024-2031³â)
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç°
  • ¼¼°èÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå Àü¸Á:¿ëµµ
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, ¿ëµµº°(2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ¿ëµµº°(2024-2031³â)
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ¿ëµµ
  • ¼¼°èÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå Àü¸Á: ÃÖÁ¾ »ç¿ëÀÚ
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, ÃÖÁ¾ »ç¿ëÀÚº°(2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾ »ç¿ëÀÚº°(2024-2031³â)
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚ

Á¦6Àå ¼¼°èÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå Àü¸Á : Áö¿ª

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ºÐ¼®, Áö¿ªº°(2019-2023³â)
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§)ÀÇ ºÐ¼®°ú ¿¹Ãø, Áö¿ªº°(2024-2031³â)
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® :Áö¿ª

Á¦7Àå ºÏ¹ÌÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

Á¦8Àå À¯·´ÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

Á¦9Àå µ¿¾Æ½Ã¾ÆÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

Á¦10Àå ³²¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾ÆÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • ½ÃÀå ±¸Á¶
    • °æÀï °­µµ ¸ÅÇÎ : ½ÃÀ庰
    • °æÀï ´ë½Ãº¸µå
  • ¿£ÅÍÇÁ¶óÀÌÁî ÇÁ·ÎÆÄÀÏ(¼¼ºÎ »çÇ× - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • Abbott
    • APEX Biotechnology Corporation
    • TaiDoc Technology Corporation
    • EKF Diagnostics Holdings plc
    • Nova Biomedical
    • KETO-MOJO
    • ACON Laboratories Inc.
    • Care Touch LLC
    • ForaCare Inc.
    • GlucoRx Ltd.
    • Nipro
    • Trividia Health, Inc.

Á¦14Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
  • µÎÀÚ¾î ¹× ¾à¾î
JHS 24.09.24

Persistence Market Research has recently published an extensive report on the global Blood Ketone Meter Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Blood Ketone Meter Market Size (2024E): US$468 Mn
  • Projected Market Value (2031F): US$750 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 7%

Blood Ketone Meter Market - Report Scope:

The Blood Ketone Meter Market encompasses a variety of devices designed to measure the level of ketones in the blood, an essential metric for individuals managing diabetes or following ketogenic diets. These meters offer accurate and quick readings, providing critical information for monitoring and managing ketone levels, which is vital for preventing conditions like ketoacidosis. The market serves a wide range of segments, including hospitals, clinics, and homecare settings. Growth is driven by the increasing prevalence of diabetes, the rising adoption of ketogenic diets, and technological advancements in point-of-care diagnostics.

Market Growth Drivers:

Several key factors are driving the global Blood Ketone Meter Market. The rising incidence of diabetes worldwide is a significant driver, as ketone monitoring is essential for diabetes management, particularly for those with type 1 diabetes. Additionally, the growing popularity of ketogenic diets for weight management and therapeutic purposes has led to an increased demand for ketone meters. Technological advancements in blood ketone meters, such as improved accuracy, ease of use, and integration with digital health platforms, further fuel market growth. Moreover, the increasing awareness of the risks associated with high ketone levels, such as diabetic ketoacidosis (DKA), has heightened the demand for reliable monitoring devices.

Market Restraints:

Despite promising growth prospects, the Blood Ketone Meter Market faces challenges related to the high cost of advanced ketone meters and the limited awareness of their importance among non-diabetic populations. Market growth can be hindered by the availability of alternative methods for ketone monitoring, such as urine ketone strips, which are less expensive but also less accurate. Additionally, concerns about the accuracy and reliability of some low-cost blood ketone meters pose challenges for market expansion. Addressing these issues requires ongoing investment in research and development to improve device accuracy, reduce costs, and enhance consumer awareness of the benefits of regular ketone monitoring.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of ketogenic diets and the rising demand for home-based monitoring solutions. The development of advanced blood ketone meters with integrated digital health features, such as mobile apps for data tracking and analysis, caters to the growing need for more personalized and convenient health monitoring solutions. The expansion of e-commerce platforms and direct-to-consumer delivery services provides new channels for market growth, allowing companies to reach a broader audience and offer convenient access to a wide variety of products. Strategic partnerships, investments in sustainable and user-friendly designs, and the introduction of multifunctional meters that can measure both glucose and ketone levels are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Blood Ketone Meter Market globally?
  • Which types and formats of blood ketone meters are leading the adoption in various healthcare settings?
  • How are technological advancements influencing the competitive landscape of the Blood Ketone Meter Market?
  • Who are the key players in the Blood Ketone Meter Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Blood Ketone Meter Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Blood Ketone Meter Market, including Abbott Laboratories, Nova Biomedical, and Roche Diagnostics, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest heavily in R&D to develop advanced blood ketone meters that offer superior accuracy, ease of use, and connectivity with digital health platforms. Collaborations with healthcare providers, pharmacies, and online retailers facilitate market access and promote new product adoption. Emphasis on consumer education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Blood Ketone Meter Market landscape.

Key Companies Profiled:

  • Abbott
  • APEX Biotechnology Corporation
  • TaiDoc Technology Corporation
  • EKF Diagnostics Holdings plc
  • Nova Biomedical
  • KETO-MOJO
  • ACON Laboratories Inc.
  • Care Touch LLC
  • ForaCare Inc.
  • GlucoRx Ltd.
  • Nipro
  • Trividia Health, Inc

Blood Ketone Meter Market Industry Segmentation

By Product

  • Blood Ketone Monitoring
  • Blood Glucose Monitoring

By Application

  • Human
  • Veterinary

By End Use

  • Hospitals
  • Diagnostic Centres
  • Homecare Settings

By Region

  • North America
  • Latin America
  • Europe
  • South Asia & Oceania
  • East Asia
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Blood Ketone Meter Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Force Analysis
  • 3.6. Parent Market Analysis

4. Price Analysis, 2023A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Blood Ketone Meter Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
    • 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
  • 5.3. Global Blood Ketone Meter Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2023
    • 5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
      • 5.3.3.1. Blood Ketone Monitoring
      • 5.3.3.2. Blood Glucose Monitoring
  • 5.4. Market Attractiveness Analysis: Product
  • 5.5. Global Blood Ketone Meter Market Outlook: Application
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
    • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
      • 5.5.3.1. Human
      • 5.5.3.2. Veterinary
  • 5.6. Market Attractiveness Analysis: Application
  • 5.7. Global Blood Ketone Meter Market Outlook: End User
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
    • 5.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
      • 5.7.3.1. Hospitals
      • 5.7.3.2. Diagnostic Centres
      • 5.7.3.3. Homecare Settings
  • 5.8. Market Attractiveness Analysis: End User

6. Global Blood Ketone Meter Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2023
  • 6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2024-2031
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Blood Ketone Meter Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 7.4.1. Blood Ketone Monitoring
    • 7.4.2. Blood Glucose Monitoring
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 7.5.1. Human
    • 7.5.2. Veterinary
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostic Centres
    • 7.6.3. Homecare Settings
  • 7.7. Market Attractiveness Analysis

8. Europe Blood Ketone Meter Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 8.4.1. Blood Ketone Monitoring
    • 8.4.2. Blood Glucose Monitoring
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 8.5.1. Human
    • 8.5.2. Veterinary
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostic Centres
    • 8.6.3. Homecare Settings
  • 8.7. Market Attractiveness Analysis

9. East Asia Blood Ketone Meter Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 9.4.1. Blood Ketone Monitoring
    • 9.4.2. Blood Glucose Monitoring
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 9.5.1. Human
    • 9.5.2. Veterinary
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic Centres
    • 9.6.3. Homecare Settings
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Blood Ketone Meter Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 10.4.1. Blood Ketone Monitoring
    • 10.4.2. Blood Glucose Monitoring
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 10.5.1. Human
    • 10.5.2. Veterinary
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic Centres
    • 10.6.3. Homecare Settings
  • 10.7. Market Attractiveness Analysis

11. Latin America Blood Ketone Meter Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 11.4.1. Blood Ketone Monitoring
    • 11.4.2. Blood Glucose Monitoring
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 11.5.1. Human
    • 11.5.2. Veterinary
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic Centres
    • 11.6.3. Homecare Settings
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Blood Ketone Meter Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By End User
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 12.4.1. Blood Ketone Monitoring
    • 12.4.2. Blood Glucose Monitoring
  • 12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 12.5.1. Human
    • 12.5.2. Veterinary
  • 12.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 12.6.1. Hospitals
    • 12.6.2. Diagnostic Centres
    • 12.6.3. Homecare Settings
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Abbott
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. APEX Biotechnology Corporation
    • 13.3.3. TaiDoc Technology Corporation
    • 13.3.4. EKF Diagnostics Holdings plc
    • 13.3.5. Nova Biomedical
    • 13.3.6. KETO-MOJO
    • 13.3.7. ACON Laboratories Inc.
    • 13.3.8. Care Touch LLC
    • 13.3.9. ForaCare Inc.
    • 13.3.10. GlucoRx Ltd.
    • 13.3.11. Nipro
    • 13.3.12. Trividia Health, Inc.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦